COLLEGIUM PHARMACEUTICAL INC (COLL) Stock Fundamental Analysis
USA - NASDAQ:COLL - US19459J1043 - Common Stock
33.74 USD
+0.53 (+1.6%)
We assign a fundamental rating of 6 out of 10 to COLL. COLL was compared to 195 industry peers in the Pharmaceuticals industry. COLL scores excellent on profitability, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on COLL.
1. Profitability
1.1 Basic Checks
In the past year COLL was profitable.
In the past year COLL had a positive cash flow from operations.
Of the past 5 years COLL 4 years were profitable.
Each year in the past 5 years COLL had a positive operating cash flow.
1.2 Ratios
COLL has a better Return On Assets (2.28%) than 84.62% of its industry peers.
COLL's Return On Equity of 15.62% is amongst the best of the industry. COLL outperforms 89.23% of its industry peers.
The Return On Invested Capital of COLL (7.69%) is better than 84.10% of its industry peers.
The Average Return On Invested Capital over the past 3 years for COLL is below the industry average of 15.30%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.28% | ||
| ROE | 15.62% | ||
| ROIC | 7.69% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
1.3 Margins
Looking at the Profit Margin, with a value of 5.13%, COLL belongs to the top of the industry, outperforming 84.10% of the companies in the same industry.
COLL's Profit Margin has declined in the last couple of years.
COLL's Operating Margin of 18.35% is amongst the best of the industry. COLL outperforms 87.18% of its industry peers.
In the last couple of years the Operating Margin of COLL has grown nicely.
The Gross Margin of COLL (56.69%) is better than 65.64% of its industry peers.
In the last couple of years the Gross Margin of COLL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.35% | ||
| PM (TTM) | 5.13% | ||
| GM | 56.69% |
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
2. Health
2.1 Basic Checks
COLL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
COLL has less shares outstanding than it did 1 year ago.
The number of shares outstanding for COLL has been reduced compared to 5 years ago.
The debt/assets ratio for COLL has been reduced compared to a year ago.
2.2 Solvency
COLL has an Altman-Z score of 1.11. This is a bad value and indicates that COLL is not financially healthy and even has some risk of bankruptcy.
COLL has a Altman-Z score (1.11) which is in line with its industry peers.
The Debt to FCF ratio of COLL is 4.08, which is a neutral value as it means it would take COLL, 4.08 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of COLL (4.08) is better than 86.67% of its industry peers.
COLL has a Debt/Equity ratio of 3.27. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 3.27, COLL is doing worse than 81.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.27 | ||
| Debt/FCF | 4.08 | ||
| Altman-Z | 1.11 |
ROIC/WACC0.9
WACC8.59%
2.3 Liquidity
A Current Ratio of 1.18 indicates that COLL should not have too much problems paying its short term obligations.
COLL has a worse Current ratio (1.18) than 77.95% of its industry peers.
A Quick Ratio of 1.10 indicates that COLL should not have too much problems paying its short term obligations.
COLL's Quick ratio of 1.10 is on the low side compared to the rest of the industry. COLL is outperformed by 72.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
COLL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.19%, which is quite impressive.
Measured over the past years, COLL shows a very strong growth in Earnings Per Share. The EPS has been growing by 154.78% on average per year.
The Revenue has grown by 22.61% in the past year. This is a very strong growth!
The Revenue has been growing by 16.31% on average over the past years. This is quite good.
EPS 1Y (TTM)48.19%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%3.7%
Revenue 1Y (TTM)22.61%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%29.41%
3.2 Future
The Earnings Per Share is expected to grow by 4.42% on average over the next years.
The Revenue is expected to grow by 3.17% on average over the next years.
EPS Next Y30.62%
EPS Next 2Y14.84%
EPS Next 3Y4.88%
EPS Next 5Y4.42%
Revenue Next Year20.25%
Revenue Next 2Y11.18%
Revenue Next 3Y4.61%
Revenue Next 5Y3.17%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 5.15, the valuation of COLL can be described as very cheap.
COLL's Price/Earnings ratio is rather cheap when compared to the industry. COLL is cheaper than 96.41% of the companies in the same industry.
When comparing the Price/Earnings ratio of COLL to the average of the S&P500 Index (27.29), we can say COLL is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 3.97, the valuation of COLL can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 98.46% of the companies listed in the same industry.
COLL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.85.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.15 | ||
| Fwd PE | 3.97 |
4.2 Price Multiples
97.95% of the companies in the same industry are more expensive than COLL, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, COLL is valued cheaper than 95.90% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.27 | ||
| EV/EBITDA | 4.52 |
4.3 Compensation for Growth
COLL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
COLL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.17
PEG (5Y)N/A
EPS Next 2Y14.84%
EPS Next 3Y4.88%
5. Dividend
5.1 Amount
No dividends for COLL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:COLL (10/17/2025, 2:55:59 PM)
33.74
+0.53 (+1.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners116.73%
Inst Owner Change0.25%
Ins Owners1.56%
Ins Owner Change1.27%
Market Cap1.06B
Analysts81.82
Price Target45.49 (34.83%)
Short Float %14.4%
Short Ratio10.76
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.92%
Min EPS beat(2)1.88%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)3.95%
Min EPS beat(4)-0.88%
Max EPS beat(4)12.85%
EPS beat(8)7
Avg EPS beat(8)12.07%
EPS beat(12)9
Avg EPS beat(12)-6.79%
EPS beat(16)9
Avg EPS beat(16)-27.3%
Revenue beat(2)2
Avg Revenue beat(2)1.62%
Min Revenue beat(2)1.34%
Max Revenue beat(2)1.9%
Revenue beat(4)3
Avg Revenue beat(4)0.71%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.9%
Revenue beat(8)3
Avg Revenue beat(8)-0.65%
Revenue beat(12)6
Avg Revenue beat(12)-0.42%
Revenue beat(16)7
Avg Revenue beat(16)-4.84%
PT rev (1m)0%
PT rev (3m)3.72%
EPS NQ rev (1m)0%
EPS NQ rev (3m)15.14%
EPS NY rev (1m)0%
EPS NY rev (3m)5.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.86%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.15 | ||
| Fwd PE | 3.97 | ||
| P/S | 1.5 | ||
| P/FCF | 5.27 | ||
| P/OCF | 5.22 | ||
| P/B | 4.58 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.52 |
EPS(TTM)6.55
EY19.41%
EPS(NY)8.51
Fwd EY25.21%
FCF(TTM)6.41
FCFY18.99%
OCF(TTM)6.46
OCFY19.15%
SpS22.44
BVpS7.37
TBVpS-22.1
PEG (NY)0.17
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.28% | ||
| ROE | 15.62% | ||
| ROCE | 11.5% | ||
| ROIC | 7.69% | ||
| ROICexc | 9.58% | ||
| ROICexgc | N/A | ||
| OM | 18.35% | ||
| PM (TTM) | 5.13% | ||
| GM | 56.69% | ||
| FCFM | 28.54% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
ROICexc(3y)16.99%
ROICexc(5y)14.94%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.56%
ROCE(5y)13.94%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y15.58%
ROICexc growth 5YN/A
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.27 | ||
| Debt/FCF | 4.08 | ||
| Debt/EBITDA | 2.22 | ||
| Cap/Depr | 0.79% | ||
| Cap/Sales | 0.24% | ||
| Interest Coverage | 1.9 | ||
| Cash Conversion | 59.64% | ||
| Profit Quality | 556.38% | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 1.11 |
F-Score5
WACC8.59%
ROIC/WACC0.9
Cap/Depr(3y)142.93%
Cap/Depr(5y)207.67%
Cap/Sales(3y)41.34%
Cap/Sales(5y)49.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.19%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%3.7%
EPS Next Y30.62%
EPS Next 2Y14.84%
EPS Next 3Y4.88%
EPS Next 5Y4.42%
Revenue 1Y (TTM)22.61%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%29.41%
Revenue Next Year20.25%
Revenue Next 2Y11.18%
Revenue Next 3Y4.61%
Revenue Next 5Y3.17%
EBIT growth 1Y-36.29%
EBIT growth 3Y89.16%
EBIT growth 5YN/A
EBIT Next Year149%
EBIT Next 3Y27.45%
EBIT Next 5Y16.08%
FCF growth 1Y-14.2%
FCF growth 3Y25.98%
FCF growth 5Y56.88%
OCF growth 1Y-13.96%
OCF growth 3Y25.54%
OCF growth 5Y49.12%